McKinley Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-2,130
Closed -$161K 316
2018
Q1
$161K Buy
2,130
+860
+68% +$68.4K 0.01% 229
2017
Q4
$91K Sell
1,270
-876
-41% -$66.5K ﹤0.01% 308
2017
Q3
$174K Sell
2,146
-29,844
-93% -$2.28M 0.01% 307
2017
Q2
$2.26M Sell
31,990
-3,595
-10% -$239K 0.08% 151
2017
Q1
$2.42M Sell
35,585
-3,905
-10% -$275K 0.09% 154
2016
Q4
$2.83M Sell
39,490
-12,767
-24% -$949K 0.11% 140
2016
Q3
$4.13M Buy
52,257
+3,794
+8% +$308K 0.15% 141
2016
Q2
$4.04M Sell
48,463
-391,421
-89% -$34.7M 0.2% 136
2016
Q1
$40.4M Sell
439,884
-46,702
-10% -$4.21M 1.95% 7
2015
Q4
$49.2M Sell
486,586
-24,915
-5% -$2.59M 2.28% 6
2015
Q3
$50.2M Buy
511,501
+92,063
+22% +$10.2M 2.44% 3
2015
Q2
$49.1M Sell
419,438
-28,646
-6% -$3.13M 2.1% 3
2015
Q1
$44M Sell
448,084
-17,205
-4% -$1.75M 1.76% 8
2014
Q4
$43.9M Sell
465,289
-13,080
-3% -$1.35M 1.76% 9
2014
Q3
$50.9M Sell
478,369
-179,739
-27% -$17.6M 2.24% 3
2014
Q2
$54.6M Sell
658,108
-32,236
-5% -$2.51M 2.24% 3
2014
Q1
$48.9M Sell
690,344
-234,255
-25% -$18.4M 2.06% 3
2013
Q4
$69.4M Buy
924,599
+12,639
+1% +$880K 2.72% 1
2013
Q3
$57.3M Sell
911,960
-6,908
-0.8% -$413K 2.51% 1
2013
Q2
$47.1M Buy
+918,868
New +$47.9M 2.37% 2

Other funds holding GILD

McKinley Capital Management's GILD Position: Q2 2018 in Review

McKinley Capital Management sold out of Gilead Sciences (GILD) in Q2 2018, closing a stake of 2,130 shares — an estimated $161K sold.

McKinley Capital Management first reported a position in GILD in Q2 2013 and held it in 20 quarters. The position peaked at $69.4M in Q4 2013. 1,522 funds tracked by Wall St. Rank hold GILD as of Q2 2018.

  • McKinley Capital Management reported no remaining Gilead Sciences position as of Q2 2018 after selling out during the quarter.
  • McKinley Capital Management sold 2,130 Gilead Sciences shares in Q2 2018, an estimated $161K.
  • McKinley Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 20 quarters.
  • McKinley Capital Management's Gilead Sciences position peaked at $69.4M in Q4 2013.
  • 1,522 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2018.

Based on McKinley Capital Management's 13F filing for Q2 2018, filed 13 Jul 2018.